Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02259725
Title Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Southern California
Indications

neuroendocrine tumor

Therapies

Regorafenib

Age Groups: adult
Covered Countries USA


No variant requirements are available.